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Aim: To evaluate real-time PCR as a diagnostic 
method for Legionnaires’ disease (LD). Detection 
of  Legionella  DNA is among the laboratory criteria of 
a probable LD case, according to the European Centre 
for Disease Prevention and Control, although the util-
ity and advantages, as compared to culture, are widely 
recognised. Methods: Two independent laboratories, 
one using an in-house and the other a commercial 
real-time PCR assay, analysed 354 respiratory sam-
ples from 311 patients hospitalised with pneumonia 
between 2010–15. The real-time PCR reliability was 
compared with that of culture and urinary antigen 
tests (UAT). Concordance, specificity, sensitivity and 
positive and negative predictive values (PPV and NPV, 
respectively) were calculated. Results: Overall PCR 
detected eight additional LD cases, six of which were 
due to  Legionella pneumophila  (Lp) non-serogroup 
1. The two real-time PCR assays were concordant in 
99.4% of the samples. Considering in-house real-time 
PCR as the reference method, specificity of culture 
and UAT was 100% and 97.9% (95% CI: 96.2–99.6), 
while the sensitivity was 63.6% (95%CI: 58.6–68.6) 
and 77.8% (95% CI: 72.9–82.7). PPV and NPV for cul-
ture were 100% and 93.7% (95% CI: 91.2-96.3). PPV 
and NPV for UAT were 87.5% (95% CI: 83.6-91.4) and 
95.8% (95% CI: 93.5-98.2). Conclusion: Regardless of 
the real-time PCR assay used, it was possible to diag-
nose LD cases with higher sensitivity than using cul-
ture or UAT. These data encourage the adoption of PCR 
as routine laboratory testing to diagnose LD and such 
methods should be eligible to define a confirmed LD 
case.
Introduction
Legionnaires’ disease (LD) is a severe form of pneu-
monia and is caused by bacteria belonging to 
the  Legionella  genus. These microorganisms are 
ubiquitous in natural freshwater environments and 
can also thrive in man-made water systems. Legionella 
pneumophila  (Lp) is the mostly responsible for the 
development of LD; serogroup 1 (sg1) is most fre-
quently isolated from clinical samples [1]. LD cannot be 
clinically or radiologically distinguished from pneumo-
nia cases of different aetiology, therefore the disease 
often remains undiagnosed. Age, underlying diseases, 
delay in diagnosis and inappropriate antibiotic therapy 
can result in an increase of the case fatality rate from 
LD [2].
In 2015, the enumeration of all cases with a known 
outcome demonstrated an average case fatality rate of 
8%, with a higher rate (28%) in nosocomial cases in 
Europe [3]. According to LD case definition [4,5], cul-
ture, a fourfold raise in Lp sg1 antibodies and urinary 
antigen test (UAT) are the only laboratory methods 
considered reliable for LD case confirmation. While 
serology has been nearly abandoned, UAT has almost 
completely replaced culture, representing 82% and 
97% of diagnosis in Europe and in the United States 
(US), respectively [1,3]. A similar trend was observed 
in Italy, where in 2016 UAT and culture were used to 
diagnose 95.5% and 2.7% of cases, respectively [6]. 
However, both culture and UAT have some limitations; 
culture is time consuming and has a sensitivity ranging 
from <  10–80% [1], UAT can be performed rapidly and 
with very high specificity for Lp sg1, but sensitivity for 
non-sg1 antigens is very low. In addition, the sensitivity 
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of UAT has been demonstrated to be lower for non-Lp 
sg1 MAb 3/1-positive strains [2]. Of note, laboratory 
diagnosis is often based on a single method, without 
taking into account the limitations that each diagnostic 
assay might have [3,7].
Diagnostic tools based on detection of nucleic acids 
are an option to overcome the limitations observed 
by both culture and UAT. The numerous PCR assays 
proposed have shown high sensitivity and specificity, 
provided fast results and were able to detect a higher 
number of cases, giving the possibility to improve sur-
veillance and better characterise local LD epidemiology 
[8-14]. Despite an increase in the proportion of cases 
diagnosed by PCR being reported in several European 
countries, the use of PCR is still very limited; presently 
a positive PCR result only defines a LD probable case 
[4,5]. Currently, in Italy, only 0.1% of LD cases are diag-
nosed by PCR [6].
The aim of this retrospective study was to evaluate 
real-time PCR as rapid diagnostic tool to define a LD 
case.
Methods
Respiratory samples were analysed using two differ-
ent real-time PCR assays, performed in two different 
laboratories.
Samples collection
A total of 369 respiratory samples (including sputa, 
bronchial-alveolar lavages and bronchial aspirates) 
collected from 326 patients admitted to hospital for 
any pneumonia between 2010 and 2015 in Italy and 
were retrospectively analysed for  Legionella pneu-
mophila DNA detection.
Clinical samples were collected by two hospital lab-
oratories, 74 samples (from 74 patients) from the 
Laboratory of Microbiology and Virology (University 
Hospital of Verona) and 295 (from 252 patients) from 
the Modena Regional Reference Laboratory (RRL) for 
Clinical Diagnosis of Legionellosis (Unit of Microbiology 
and Virology-Polyclinic University Hospital). All clinical 
samples were obtained 1 or 2 days after the onset of 
symptoms except three samples that were collected 5 
days after onset of the disease. After collection, res-
piratory samples were stored at - 80 °C until tested.
Furthermore, 278 urine samples were available from 
246 patients. There were 74 urine samples from 74 
patients from Verona and 204 urine samples from 172 
patients from Modena RRL.
Culture examination and urinary antigen test
While patients were hospitalised with pneumo-
nia symptoms, the Laboratory of Microbiology 
and Virology of Verona and the Modena RRL per-
formed  Legionella  culture and UAT. For 25 patients 
culture was performed on two different respiratory 
samples and for nine patients on three samples, while 
for the remaining patients culture was performed on 
only one sample. Culture was carried out according to 
the procedures described elsewhere [15].
Both laboratories performed UAT by using both 
BinaxNOW Legionella Urinary Antigen Card kit and 
Binax Legionella Urinary Antigen EIA kit (Alere, 
Scarborough, US). Urine samples were always boiled 
before testing. For 19 patients UAT was performed on 
two urinary samples and for eight patients on three 
samples.
Real-time PCR
DNA extraction was performed at the Modena RRL 
using the ELITe STAR 200 Extraction kit (ELITechGroup 
S.p.A, Torino, Italy). DNA extracts were split in two ali-
quots to be analysed by real-time PCR at the Modena 
RRL and at the National Reference Laboratory at the 
Istituto Superiore di Sanità in Rome.
The Modena RRL analysed 5μL of DNA with the CE IVD 
marked real-time PCR commercial kit Legionella pn. 
Q-PCR Alert (ELITechGroup, CE IVD marked) detect-
ing for Lp  mip  gene, according to the manufacturer’s 
instructions on a 7300 Real-Time PCR System (Applied 
Biosystems, Foster City, California (CA), US). The NRL 
also analysed 5μL of DNA using an in-house real-time 
PCR assay in a final volume of 20μL, containing 10μL 
of EXPRESS qPCR SuperMix, (Invitrogen, Carlsbad, 
CA, US), with Chromo 4 BioRad instrument (Bio-Rad, 
Hercules, CA, US), updated to CFX-96, and the follow-
ing thermal protocol: 5 minutes at 95°C followed by 
Table 1
Clinical samples analysed for admitted patients, Italy, 2010–15 (n = 311)
Number of tested 
samples
Number of positive 
samples
Number of negative 
samples
Number of individuals 
tested
In-house real-time PCR assay 354 55 299 311
Commercial real-time PCR assay 354 53 301 311
UAT 278 40 238 246
Culture 354 35 319 311
PCR: polymerase chain reaction; UAT: urinary antigen test.
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45 cycles of denaturation at 95°C for 10 seconds and 
annealing/extension at 60  °C for 15 seconds. Primers 
and probes were as described by Mentasti et al. [14], 
targeting mip and wzm genes for detection of Lp (sg1–
15) and sg1 marker, respectively. Primers and probes 
for internal control DNA were also as already described 
[14].
Statistical analysis
The concordance between tests was evaluated using 
the Kappa test (K < 0.20 = “poor”; 0.20–0.40 = “fair”; 
0.40–0.60 = “moderate”; 0.60–0.80 = “good”; 0.80–
1.00 = “very good”). The specificity, sensitivity and the 
positive and negative predictive values (PPV and NPV, 
respectively) and 95% confidence intervals (CI) for all 
methods were calculated considering the in-house 
real-time PCR as a reference method. In addition, the 
concordance between all methods was also calculated. 
All statistical analyses were performed by Stata soft-
ware version 11.2 (StataCorp, Texas, US).
Results
Samples analysed by real-time PCR, culture 
and urinary antigen test
Of 369 DNA samples, 15 were excluded from the 
comparison with culture and UAT because they were 
inhibitory in both PCR assays, as demonstrated by the 
absence of amplification of the internal control. These 
samples were also found negative for culture and 
UAT. Therefore, 354 samples from 311 patients were 
included in the comparison of PCR results with culture 
and/or UAT results (Table 1).
Both commercial and in-house real-time PCR assays 
gave the same results in 352 out of 354 samples, of 
which 299 (85%) were negative and 53 (15%) were posi-
tive (53 positive for  mip  marker and six positive also 
for  wzm  target). The in-house PCR detected two more 
positive samples (n = 55) compared with the commercial 
one. Of the 354 samples analysed by in-house PCR, 
six samples, (five negatives for both culture and UAT 
and one negative only for UAT but positive for culture) 
were identified as Lp non-sg1. Since the in-house PCR 
assay was able to differentiate Lp sg1 from the other 
serogroups, it was arbitrarily considered as a reference 
assay.
The concordance of the two PCR assays (commercial 
vs in-house) was 99.4% with a K  =  0.98 (p  <  0.0001). 
Specificity and sensitivity of commercial PCR assay 
were calculated equal to 100% and 96.4% (95% CI: 
94.4–98.3) respectively.
All 354 respiratory samples were also tested by culture; 
of these, 35 (9.9%) were positive.
A total of 278 urine samples were tested by UAT and 
40 (14.3%) were found positive. The two methods used 
to detect the urinary antigen were concordant on all 
tested samples.
Legionnaires’ disease cases detected
The total number of LD cases detected was 52 (Table 
2) and it was calculated considering the patients with 
at least one positive diagnostic test (culture, UAT and 
PCR). The in-house PCR assay was considered as a ref-
erence for comparison with culture and UAT results.
Using culture and/or urinary antigen test for diagnosis, 
the number of LD cases detected was 44; when the in-
house PCR assay was added, the number of detected 
cases increased to 52 (Table 2). PCR confirmed LD diag-
nosis in 84.6% of cases with at least one traditional 
diagnostic criterion positive (culture or UAT or both) 
and an increment of 18.2% was observed.
The comparison between culture and the in-house real-
time PCR assay showed that the sensitivity of culture 
(63.6%; 95% CI: 58.6–68.6) was lower, while the speci-
ficity was 100%. The PPV and the NPV were 100% and 
93.7% (95% CI: 91.2-96.3), respectively. Overall con-
cordance was good (94.3%; k = 0.75; p < 0.0001) (Table 
3).
The comparison between UAT and the in-house PCR 
showed a higher sensitivity (77.8%; 95% CI: 72.9–82.7) 
than between culture and PCR, while specificity was 
slightly lower (97.9%; 95% CI: 96.2–99.6), and PPV and 
NPV were 87.5% (95% CI: 83.6–91.4) and 95.8% (95% 
CI: 93.5–98.2) respectively. Overall concordance of the 
two assays was good (94.6%; k  =  0.79; p  <  0.0001) 
(Table 3).
Discussion
In this study two independent laboratories, using a dif-
ferent real-time PCR assay for  Legionella pneumoph-
ila  DNA detection, analysed 354 respiratory samples 
and provided results with a very high concordance 
(99.4%).
Our results highlight a higher sensitivity of PCR com-
pared with culture and a higher diagnostic efficiency 
compared with UAT. Furthermore, as recently stressed 
Table 2
Legionnaires’ disease cases with at least one positive 
diagnostic test, Italy, 2010–15 (n = 52)
Culture Urinary antigen test
In-house real-
time PCR
Number of cases 
 
N = 52
Positive   Positive   Positive 21
Positive Negative  Positive 3
Positive ND    Positive 5
Negative   Positive  Positive 10
Negative ND   Positive 3
Negative Negative  Positive 5
Negative  Positive  Positive 5
ND: not done.
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by other authors [16,17], it is important to perform more 
than one diagnostic assay in order to properly diag-
nose LD. Five of the eight LD cases with negative UAT 
results would have been missed if PCR assays, able 
to detect all Lp serogroups, had not been performed. 
Although in some instances UAT can incidentally detect 
non-1 Lp serogroups, they are designed to specifically 
detect Lp1 antigen, therefore, negative UAT results do 
not completely rule out LD infection. In addition to the 
aforementioned five cases (negative for UAT and for 
culture), three more culture-negative cases, resulted 
positive for Lp DNA by PCR. For these three, clinicians 
had only requested cultures and did not request UAT. 
Overall the eight additional cases show that even with 
a negative diagnosis but in presence of pneumonia, LD 
infection should be suspected and all available tests 
performed to investigate it.
Considering that urine samples were boiled before 
testing to destroy heat-sensitive proteins that could 
affect the test, false positive results can be reasonably 
excluded [7]. A possible explanation for the five UAT-
positive but PCR-negative cases was obtained query-
ing patients’ records: for two patients a sputum sample 
was promptly collected and analysed, while for the 
others sputum analysis was requested 5 or more days 
after the antibiotic therapy was started. Although there 
are not sufficient data to show if and how PCR results 
might be affected by an on-going antibiotic therapy, 
the above observation suggests the need to perform 
PCR assay as soon as possible, ideally before or imme-
diately after the initiation of the antibiotic treatment.
The NPV was suggestive of the excellent reliability of 
the PCR methods, even though only Lp DNA was tar-
geted. However, this limitation can often be found 
also using culture method, because specific and 
selective  Legionellaisolation media, such as buff-
ered charcoal yeast extract (BCYE) and glycine van-
comycin polymyxin cycloheximide (GVPC), poorly 
support  Legionella  non-pneumophila  growth [18]. The 
PPV was also consistent with a higher sensitivity of 
PCR than culture.
The reliability of PCR in diagnosing LD is more and more 
recognised by the scientific community and recent 
studies demonstrated a better performance of PCR 
compared with other diagnostic assays, regardless of 
the type of respiratory sample (bronchoalveolar lavage 
or sputum) [9,13]. Moreover, PCR can also detect the 
presence of all  Legionella  species some of which are 
notoriously difficult to isolate by culture [19].
In this study, the use of real-time PCR resulted in an 
increment of eight (18.2%) identified LD cases and 
therefore is an objective improvement in the diagnosis 
of LD. Real-time PCR has been considered a poorly reli-
able method due to the risk of cross-contaminations, 
however, the introduction of automated procedures for 
DNA extractions and also for PCR set up, has resulted 
in a consistent improvement in preventing this PCR 
drawback. Therefore, after an appropriate validation of 
their own molecular tests, clinical microbiology labo-
ratories can adopt PCR assays to detect  Legionella  in 
respiratory samples.
The adoption of rapid methods to quickly identify LD 
cases is a priority, as the infection rate is underesti-
mated all over the world and difficult to quantify, and 
increasing in several countries [2,3,20]. The labora-
tory procedures currently used to define confirmed 
LD cases are not able to guarantee a high level of 
sensitivity and specificity of results and they can be 
time-consuming. As a rapid LD diagnosis is crucial for 
both patient management and public health purposes, 
real-time PCR should be considered and implemented 
both locally and at Legionella reference laboratories in 
combination with all the other available methods.
In conclusion, as already observed in other countries, 
this study shows that the introduction of real-time PCR 
can improve LD diagnosis and should be considered 
among the criteria to define confirmed cases of LD [13].
Table 3
Comparison of culture and UAT vs in-house real-time PCR by sensitivity, specificity, PPV, NPV, concordance and kappa 
value, Italy, 2010–15
Comparison Sensitivity (95% CI) Specificity (95% CI)
PPV 
 
(95% CI)
NPV 
 
(95% CI)
Concordance (%) Kappa value p-value
Culture vs 
real-time PCR in-house
63.6 
 
(58.6–68.6)
100.0 100.0
93.7 
 
(91.2–
96.3)
94.3 0.75 < 0.0001
UAT vs 
real-time PCR in-house
77.8 
 
(72.9–82.7)
97.9 
 
(96.2–99.6)
87.5 
 
(83.6–91.4)
95.8 
 
(93.5–
98.2)
94.6 0.79 < 0.0001
CI: confidence interval; NPV: negative predictive value; PCR: polymerase chain reaction; PPV: positive predictive value; UAT: urinary antigen 
test.
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